BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Obeng S, Hiranita T, León F, McMahon LR, McCurdy CR. Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. J Med Chem 2021;64:6523-48. [PMID: 33956427 DOI: 10.1021/acs.jmedchem.1c00028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Fu K, Xu W, Yang R, Zhao H, Xu H, Wei Y, Liu H, Qiu Y, Chen D, Guo D, Xiong B. 2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance. European Journal of Medicinal Chemistry 2023. [DOI: 10.1016/j.ejmech.2023.115178] [Reference Citation Analysis]
2 Su D, Gong Y, Li S, Yang J, Nian Y. Cyclovirobuxine D, a cardiovascular drug from traditional Chinese medicine, alleviates inflammatory and neuropathic pain mainly via inhibition of voltage-gated Ca(v)3.2 channels. Front Pharmacol 2022;13:1081697. [PMID: 36618940 DOI: 10.3389/fphar.2022.1081697] [Reference Citation Analysis]
3 Liu S, Li C, You S, Yan Q, Luo S, Fu Y. Synthesis and Characterization of an Analgesic Potential Conotoxin Lv32.1. Molecules 2022;27. [PMID: 36500709 DOI: 10.3390/molecules27238617] [Reference Citation Analysis]
4 Obeng S, Leon F, Patel A, Zuarth Gonzalez JD, Chaves Da Silva L, Restrepo LF, Gamez-Jimenez LR, Ho NP, Guerrero Calvache MP, Pallares VLC, Helmes JA, Shiomitsu SK, Soto PL, McCurdy CR, McMahon LR, Wilkerson JL, Hiranita T. Interactive Effects of µ-Opioid and Adrenergic-α (2) Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine. J Pharmacol Exp Ther 2022;383:182-98. [PMID: 36153006 DOI: 10.1124/jpet.122.001192] [Reference Citation Analysis]
5 Tolentino KT, Mashinson V, Sharma MK, Chhonker YS, Murry DJ, Hopkins CR. From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of σ1 modulators. European Journal of Medicinal Chemistry 2022;244:114840. [DOI: 10.1016/j.ejmech.2022.114840] [Reference Citation Analysis]
6 Ferrisi R, Gado F, Polini B, Ricardi C, Mohamed KA, Stevenson LA, Ortore G, Rapposelli S, Saccomanni G, Pertwee RG, Laprairie RB, Manera C, Chiellini G. Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R). Front Chem 2022;10:984069. [PMID: 36238097 DOI: 10.3389/fchem.2022.984069] [Reference Citation Analysis]
7 Xia F, Du SZ, Wu MK, Liu R, Ye YS, Yang J, Xu G, Nian Y. Icetexane diterpenoids as Cav3.2 T-type calcium channel inhibitors from Salvia prattii and analgesic effect of their Semi-synthesized derivatives. Bioorg Chem 2022;128:106059. [PMID: 35933895 DOI: 10.1016/j.bioorg.2022.106059] [Reference Citation Analysis]
8 Griffett K. Targeting Nuclear Receptors for Chronic Inflammatory Pain: A Potential Alternative. ACS Pharmacol Transl Sci 2022;5:440-4. [PMID: 35711817 DOI: 10.1021/acsptsci.2c00063] [Reference Citation Analysis]
9 Kargbo RB. 5-HT Receptor Modulators for Therapeutic Use in the Treatment of Obsessive-Compulsive Disorder and Other Psychological Disorders. ACS Med Chem Lett 2022;13:770-2. [PMID: 35586441 DOI: 10.1021/acsmedchemlett.2c00153] [Reference Citation Analysis]
10 Sabnis RW. 5-Oxopyrrolidine-3-carboxamides as Nav1.8 Inhibitors for Treating Pain Disorders, Cough Disorders, and Acute and Chronic Itch Disorders. ACS Med Chem Lett 2022;13:761-2. [PMID: 35586433 DOI: 10.1021/acsmedchemlett.2c00144] [Reference Citation Analysis]
11 Kargbo RB. 3-Pyrrolidine-indole Derivatives as 5-HT2-Selective Receptor Modulators for the Potential Treatment of Mental Disorders. ACS Med Chem Lett 2022;13:749-51. [PMID: 35586424 DOI: 10.1021/acsmedchemlett.2c00128] [Reference Citation Analysis]
12 Kargbo RB. Selective Serotonin Receptor Modulators for Use in the Treatment of Psychological Disorders. ACS Med Chem Lett 2022;13:534-6. [PMID: 35450370 DOI: 10.1021/acsmedchemlett.2c00110] [Reference Citation Analysis]
13 Kargbo RB. Improved Metabolically Stable 5-HT Receptor Modulators and the Development of New Antidepressants. ACS Med Chem Lett 2022;13:537-9. [PMID: 35450349 DOI: 10.1021/acsmedchemlett.2c00129] [Reference Citation Analysis]
14 Puls K, Schmidhammer H, Wolber G, Spetea M. Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors. Molecules 2022;27:919. [PMID: 35164182 DOI: 10.3390/molecules27030919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kitano Y, Shinozuka T. Inhibition of NaV1.7: the possibility of ideal analgesics. RSC Med Chem 2022;13:895-920. [DOI: 10.1039/d2md00081d] [Reference Citation Analysis]
16 Hiranita T, Obeng S, Sharma A, Wilkerson JL, Mccurdy CR, Mcmahon LR. In vitro and in vivo pharmacology of kratom. Behavioral Pharmacology of Drug Abuse: Current Status 2022. [DOI: 10.1016/bs.apha.2021.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kargbo RB. Improved 5-HT2 Selective Receptor Modulators for the Treatment of Psychological Disorders. ACS Med Chem Lett 2021;12:1876-8. [PMID: 34917242 DOI: 10.1021/acsmedchemlett.1c00578] [Reference Citation Analysis]
18 Kargbo RB. The Psychedelic Renaissance: Addressing Potential Adverse Effects in a Therapeutic Setting. ACS Med Chem Lett 2021;12:1874-5. [PMID: 34917241 DOI: 10.1021/acsmedchemlett.1c00577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Kargbo RB. 5-MeO-DMT: Potential Use of Psychedelic-Induced Experiences in the Treatment of Psychological Disorders. ACS Med Chem Lett 2021;12:1646-8. [PMID: 34795854 DOI: 10.1021/acsmedchemlett.1c00546] [Reference Citation Analysis]
20 Kargbo RB. Psychedelic Therapeutic: Potential Treatment for Headache Disorders. ACS Med Chem Lett 2021;12:1534-6. [PMID: 34676034 DOI: 10.1021/acsmedchemlett.1c00497] [Reference Citation Analysis]
21 Spetea M, Schmidhammer H. Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-ones. Molecules 2021;26:5677. [PMID: 34577147 DOI: 10.3390/molecules26185677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]